You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Hypothesis
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Multiple Sclerosis/ Demyelinating Disease
 •Alert me on articles by topic

Medical Hypothesis

Why Secondary Progressive Multiple Sclerosis Is a Relentlessly Progressive Illness

Robert M. Herndon, MD

Arch Neurol. 2002;59:301-304.

Secondary progressive multiple sclerosis is a relentlessly progressive, usually ascending, disease process. Once secondary progression begins, regardless of how long the disease was present before secondary progression began, patients appear to progress at a uniform rate. Recent studies show that it responds poorly to medications effective in relapsing remitting disease, although these drugs decrease relapses and have a substantial effect on lesions seen on magnetic resonance imaging. Disruption of axonal transport is known to occur in demyelinated fibers. Synapses, vacated when axons are destroyed, cause sprouting in surviving terminal axons, resulting in metabolic overload in the terminal axons. This noninflammatory process would not be expected to be altered by current disease-altering therapies.


From the Department of Neurology, Sonny V. Montgomery Department of Veterans Affairs Medical Center and University of Mississippi Medical Center, Jackson.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of drugs in secondary disease progression in patients with multiple sclerosis
Kappos
Mult Scler 2004;10:S46-S55.
ABSTRACT  

Dysmyelinated Lower Motor Neurons Retract and Regenerate Dysfunctional Synaptic Terminals
Yin et al.
J. Neurosci. 2004;24:3890-3898.
ABSTRACT | FULL TEXT  

Obstacles in the diagnosis and treatment of syphilitic amyotrophy
Etgen et al.
Neurology 2003;60:509-511.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.